Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Glas

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Breast (Edinburgh, Scotland)|January 26, 2013
Additional prognostic value of the 70-gene signature (MammaPrint(®)) among breast cancer patients with 4-9 positive lymph nodesM Saghatchian, S Mook, G Pruneri, et al.
Blood|July 27, 2000
B-cell-autonomous somatic mutation deficit following bone marrow transplantA M Glas, E H van Montfort, J Storek, et al.
British Journal of Cancer|September 29, 2005
No common denominator for breast cancer lymph node metastasisB Weigelt, L F A Wessels, A J Bosma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2009
The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of ageS Mook, M K Schmidt, B Weigelt, et al.
Breast Cancer Research : BCR|June 19, 2023
BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancerM C Liefaard, A van der Voort, M S van Ramshorst, et al.
Breast Cancer Research and Treatment|September 27, 2008
Validation of 70-gene prognosis signature in node-negative breast cancerJ M Bueno-de-Mesquita, S C Linn, R Keijzer, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Breast (Edinburgh, Scotland)|January 26, 2013
Additional prognostic value of the 70-gene signature (MammaPrint(®)) among breast cancer patients with 4-9 positive lymph nodesM Saghatchian, S Mook, G Pruneri, et al.
Blood|July 27, 2000
B-cell-autonomous somatic mutation deficit following bone marrow transplantA M Glas, E H van Montfort, J Storek, et al.
British Journal of Cancer|September 29, 2005
No common denominator for breast cancer lymph node metastasisB Weigelt, L F A Wessels, A J Bosma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2009
The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of ageS Mook, M K Schmidt, B Weigelt, et al.
Breast Cancer Research : BCR|June 19, 2023
BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancerM C Liefaard, A van der Voort, M S van Ramshorst, et al.
Breast Cancer Research and Treatment|September 27, 2008
Validation of 70-gene prognosis signature in node-negative breast cancerJ M Bueno-de-Mesquita, S C Linn, R Keijzer, et al.
Pageof 2